Ameloblastoma
Watchlist
Retrieved
2022-04-26
Source
Trials
—
Genes
BRAF,
SMO,
TP53,
CTNNB1,
BCL2,
PTCH1,
HSPG2,
MMP2,
MMP9,
AMBN,
TP63,
TNFSF11,
IL6,
EWSR1,
TIMP2,
EGFR,
VIM,
PDPN,
GLI1,
CKAP4,
CD34,
UVRAG,
MDM2,
RPE65,
MSH2,
MLH1,
WNT1,
HRAS,
CXCL8,
NOTCH1
BRAF,
SMO,
TP53,
CTNNB1,
BCL2,
PTCH1,
HSPG2,
MMP2,
MMP9,
AMBN,
TP63,
TNFSF11,
IL6,
EWSR1,
TIMP2,
EGFR,
VIM,
PDPN,
GLI1,
CKAP4,
CD34,
UVRAG,
MDM2,
RPE65,
MSH2,
MLH1,
WNT1,
HRAS,
CXCL8,
NOTCH1,
FGFR2,
ITGB1,
COX2,
PCNA,
RECK,
CCND1,
SS18,
CALB2,
PTGS2,
CD44,
SDC1,
MAP2K7,
CDKN2A,
ZEB1,
SDC2,
MTCO2P12,
SHH,
SPARC,
KMT2D,
RBM10,
AXIN1,
MOGS,
TUFT1,
SSX2,
XRCC1,
TP73,
SYT1,
TGFB2,
TNF,
EZR,
VEGFA,
TNFRSF1A,
AXIN2,
STAT3,
ACTB,
TNFRSF25,
ARMH1,
SF3B6,
SUFU,
MIB1,
ARHGAP24,
ING5,
MARCHF10,
FAM83H,
POU5F1P3,
SNORA65,
POU5F1P4,
GGTLC5P,
SSX2B,
GGTLC3,
GGT2,
GGTLC4P,
H3P8,
LAMTOR2,
BAMBI,
TNFSF10,
RABEPK,
TNFRSF11A,
TNFRSF10A,
ARHGEF2,
SOX2,
FAM30A,
BCL2L11,
ENAM,
CDK2AP2,
QPCT,
LANCL1,
POSTN,
HPSE,
SUB1,
EBNA1BP2,
RPP14,
CADM1,
MSC,
PI3,
S100A9,
FGFR1,
ERBB3,
ERBB4,
FGF2,
FGF3,
FGF7,
FGF10,
FLI1,
HIF1A,
FOS,
MTOR,
GGT1,
GPC3,
GNAS,
GPC1,
ERBB2,
EPHB4,
DAG1,
CCN2,
CDK4,
CDH18,
CD68,
CASP8,
DDR1,
BMP4,
BMP2,
BGN,
APC,
AMELY,
AMELX,
AKT1,
NR0B1,
HGF,
TNC,
RPS6KB1,
PDGFRA,
NOTCH2,
NOTCH3,
NOTCH4,
DDR2,
TNFRSF11B,
PDGFA,
JAG1,
IBSP,
POU5F1,
MAPK1,
MAPK3,
PSMD7,
PTHLH,
RAF1,
MYC,
MMP14,
MMP1,
MKI67,
RPSA,
KRT19,
KRT14,
KRAS,
JAG2,
ITGA5,
ITGA3,
ITGA2,
ISL1,
ING2,
ING1,
IL9,
IL1A,
H3P28
Registered!
Ameloblastoma is a rare, noncancerous (benign) tumor that typically develops in the jaw near the molars. It originates in the cells that form the enamel that protects your teeth. The condition most often occurs in adults in their 30s and 40s, though it can occur at any age. In many cases, the first sign is painless swelling in the jaw. While it can be very aggressive, these tumors are rarely found outside of the jaw. Treatment is complete surgical removal of the affected tissue.